Surgical management of retinopathy of prematurity

Current Opinion in Ophthalmology

Volumn 19, Issue 5, 2008, Pages 384-390

  Hubbard, G Baker ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY EYE CENTER   (United States)

Author keywords

Laser; Plus disease; Retinal detachment; Retinopathy of prematurity; Vitrectomy

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE; MONOCLONAL ANTIBODY;

APNEA; BRADYCARDIA; CLINICAL FEATURE; COMPUTER PROGRAM; CRYOTHERAPY; DISEASE COURSE; DRUG SAFETY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LASER COAGULATION; LASER SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; REVIEW; SCLERA BUCKLING PROCEDURE; SURGICAL TECHNIQUE; THERAPY EFFECT; TREATMENT INDICATION; VITRECTOMY; VITREORETINOPATHY; VITREOUS HEMORRHAGE; NEWBORN;

ANTIBODIES, MONOCLONAL; HUMANS; INFANT, NEWBORN; LASER COAGULATION; RETINAL DETACHMENT; RETINOPATHY OF PREMATURITY; SCLERAL BUCKLING; VITRECTOMY;

EID: 53049099189     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328309f1a5     Document Type: Review

References (64)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988; 106:471-479.
2. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121:1684-1694.
3. Coats D, Saunders R. The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity. Arch Ophthalmol 2005; 123:408-409; discussion 409-410.
4. Fielder AR, Wilkinson AR. The further refinement of ROP treatment. Commentary on the early treatment of retinopathy of prematurity study: structural findings at 2 years of age. Br J Ophthalmol 2007; 91:136-137.
5. Chiang MF, Jiang L, Gelman R, et al. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol 2007; 125:875-880.
6. Wallace DK, Quinn GE, Freedman SF, Chiang MF. Agreement among pediatric ophthalmologists in diagnosing plus and preplus disease in retinopathy of prematurity. J AAPOS 2008 [Epub ahead of print].
7. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123:991-999.
8. Johnson KS, Mills MD, Karp KA, Grunwald JE. Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease. Am J Ophthalmol 2007; 143:723-725.
9. Wallace DK, Freedman SF, Zhao Z, Jung SH. Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol 2007; 125:1523-1530.
10. Swanson C, Cocker KD, Parker KH, et al. Semiautomated computer analysis of vessel growth in preterm infants without and with ROP. Br J Ophthalmol 2003; 87:1474-1477.
11. Heneghan C, Flynn J, O'Keefe M, Cahill M. Characterization of changes in blood vessel width and tortuosity in retinopathy of prematurity using image analysis. Med Image Anal 2002; 6:407-429.
12. Wallace DK, Jomier J, Aylward SR, Landers MB 3rd. Computer-automated quantification of plus disease in retinopathy of prematurity. J AAPOS 2003; 7:126-130.
13. Gelman R, Martinez-Perez ME, Vanderveen DK, et al. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image MultiScale Analysis. Invest Ophthalmol Vis Sci 2005; 46:4734-4738.
14. Rabinowitz MP, Grunwald JE, Karp KA, et al. Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age. Arch Ophthalmol 2007; 125:1495-1500.
15. Lofqvist C, Andersson E, Sigurdsson J, et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 2006; 124:1711-1718.
16. Connolly BP, Ng EY, McNamara JA, et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology 2002; 109:936-941.
17. Ng EYJ, Connolly BP, McNamara JA, et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 2002; 109:928-934; discussion 935.
18. White JE, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome. J Pediatr Ophthalmol Strabismus 1997; 34:83-87; quiz 121-122.
19. Shalev B, Farr AK, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol 2001; 132:76-80.
20. Paysse EA, Lindsey JL, Coats DK, et al. Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity. J AAPOS 1999; 3:234-240.
21. Allegaert K, Devlieger H, Casteels I. Reduced inflammatory response after laser photocoagulation compared with cryoablation for threshold retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2005; 42:264-266.
22. Woodhead DD, Lambert DK, Molloy DA, et al. Avoiding endotracheal intubation of neonates undergoing laser surgery for retinopathy of prematurity. J Perinatol 2007; 27:209-213.
23. Kirwan C, O'Keefe M, Prendergast M, et al. Morphine analgesia as an alternative to general anaesthesia during laser treatment of retinopathy of prematurity. Acta Ophthalmol Scand 2007; 85:644-647.
24. Lyon F, Dabbs T, O'Meara M. Ketamine sedation during the treatment of retinopathy of prematurity. Eye 2008; 22:684-686.
25. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007; 10:133-140.
26. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113:363e5-372e5.
27. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006; 26:275-278.
28. Travassos A, Teixeira S, Ferreira P, et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 2007; 38:233-237.
29. Chung EJ, Kim JH, Ahn HS, Koh HJ. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007; 245:1727-1730.
30. Quiroz-Mercado H, Ustariz-Gonzalez O, Martinez-Castellanos MA, et al. Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story. Semin Ophthalmol 2007; 22:109-125.
31. Shah PK, Narendran V, Tawansy KA, et al. Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol 2007; 55:75-76.
32. Honda S, Hirabayashi H, Tsukahara Y, Negi A. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefe's Arch Clin Exp Ophthalmol (Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie) 2008; 246:1061-1063.
33. Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. The Early Treatment for Retinopathy of Prematurity Study: structural findings at age 2 years. Br J Ophthalmol 2006; 90:1378-1382.
34. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome: structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1990; 108:1408-1416.
35. Multicenter trial of cryotherapy for retinopathy of prematurity. 31/2-year outcome: structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1993; 111:339-344.
36. Palmer EA, Hardy RJ, Dobson V, et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 2005; 123:311-318.
37. Repka MX, Tung B, Good WV, et al. Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP). Arch Ophthalmol 2006; 124:24-30.
38. Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology 2001; 108:2068-2070.
39. Hubbard GB III, Cherwick DH, Burian G. Lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Ophthalmology 2004; 111:2274-2277.
40. Moshfeghi AA, Banach MJ, Salam GA, Ferrone PJ. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Arch Ophthalmol 2004; 122:181 6-1818.
41. Lakhanpal RR, Sun RL, Albini TA, Holz ER. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology 2005; 112:1569-1573.
42. Yu YS, Kim SJ, Kim SY, et al. Lens-sparing vitrectomy for stage 4 and stage 5 retinopathy of prematurity. Korean J Ophthalmol 2006; 20:113-117.
43. Hartnett ME, Maguluri S, Thompson HW, McColm JR. Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Retina 2004; 24:753-757.
44. Sears JE, Sonnie C. Anatomic success of lens-sparing vitrectomy with and without scleral buckle for stage 4 retinopathy of prematurity. Am J Ophthalmol 2007; 143:810-813.
45. Vinekar A, Trese MT, Capone A Jr. Evolution of retinal detachment in posterior retinopathy of prematurity: impact on treatment approach. Am J Ophthalmol 2008; 145:548-555.
46. Micelli Ferrari T, Furino C, Lorusso VV, et al. Three-port lens-sparing vitrectomy for aggressive posterior retinopathy of prematurity: early surgery before tractional retinal detachment appearance. Eur J Ophthalmol 2007; 17:785-789.
47. Azuma N, Ishikawa K, Hama Y, et al. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol 2006; 142:636-643.
48. Flynn JT, Chan-Ling T. Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease. Am J Ophthalmol 2006; 142:46-59.
49. Cusick M, Charles MK, Agron E, et al. Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity. Retina 2006; 26:729-735.
50. Lakhanpal RR, Fortun JA, Chan-Kai B, Holz ER. Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity. Retina 2006; 26:736-740.
51. Tsukahara Y, Honda S, Imai H, et al. Autologous plasmin-assisted vitrectomy for stage 5 retinopathy of prematurity: a preliminary trial. Am J Ophthalmol 2007; 144:139-141.
52. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001; 108:1902-1905; discussion 1905-1906.
53. Wu WC, Drenser KA, Capone A, et al. Plasmin enzyme-assisted vitreoretinal surgery in congenital X-linked retinoschisis: surgical techniques based on a new classification system. Retina 2007; 27:1079-1085.
54. Tasman W. Vitreoretinal changes in cicatricial retrolental fibroplasia. Trans Am Ophthalmol Soc 1970; 68:548-594.
55. Tufail A, Singh AJ, Haynes RJ, et al. Late onset vitreoretinal complications of regressed retinopathy of prematurity. Br J Ophthalmol 2004; 88:243-246.
56. Faris BM, Brockhurst RJ. Retrolental fibroplasia in the cicatrical stage. The complication of rhegmatogenous retinal detachment. Arch Ophthalmol 1969; 82:60-65.
57. Tasman W. Retinal detachment in retrolental fibroplasia. Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 1975; 195:129-139.
58. Park KH, Hwang JM, Choi MY, et al. Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years. Retina 2004; 24:368-375.
59. Sneed SR, Pulido JS, Blodi CF, et al. Surgical management of late-onset retinal detachments associated with regressed retinopathy of prematurity. Ophthalmology 1990; 97:179-183.
60. Kaiser RS, Trese MT, Williams GA, Cox MS Jr. Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears. Ophthalmology 2001; 108:1647-1653.
61. Jandeck C, Kellner U, Foerster MH. Late retinal detachment in patients born prematurely: outcome of primary pars plana vitrectomy. Arch Ophthalmol 2004; 122:61-64.
62. Ruth A, Hutchinson AK, Hubbard GB III. Late vitreous hemorrhage in patients with regressed retinopathy of prematurity. J AAPOS 2008; 12:181-185.
63. Spirn MJ, Lynn MJ, Hubbard GB III. Vitreous hemorrhage in children. Ophthalmology 2006; 113:848-852.
64. Hutcheson KA, Nguyen AT, Preslan MW, et al. Vitreous hemorrhage in patients with high-risk retinopathy of prematurity. Am J Ophthalmol 2003; 136:258-263.